Innophos Holdings Inc Stock as Institutional Investors Exit

May 16, 2018 - By Darren Young

Sentiment for Innophos Holdings Inc (NASDAQ:IPHS)

Innophos Holdings Inc (NASDAQ:IPHS) institutional sentiment decreased to 1.1 in Q4 2017. Its down -0.26, from 1.36 in 2017Q3. The ratio has worsened, as 90 institutional investors started new and increased stock positions, while 82 sold and reduced their positions in Innophos Holdings Inc. The institutional investors in our partner’s database now hold: 18.14 million shares, down from 18.37 million shares in 2017Q3. Also, the number of institutional investors holding Innophos Holdings Inc in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 28 Reduced: 54 Increased: 50 New Position: 40.

Innophos Holdings, Inc., through its subsidiaries, produces performance-critical and nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care, and industrial end markets. The company has market cap of $918.86 million. It operates through Food, Health & Nutrition, Industrial Specialties, and Other divisions. It has a 41.61 P/E ratio. The companyÂ’s specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture additives in cheeses; leavening agents in baked goods; mineral and botanical sources for nutritional supplements; pharmaceutical excipients; and abrasives in toothpaste, as well as in industrial applications, such as asphalt modification and petrochemical catalysis.

The stock increased 0.58% or $0.27 during the last trading session, reaching $47.02. About 9,226 shares traded. Innophos Holdings, Inc. (NASDAQ:IPHS) has declined 27.20% since May 16, 2017 and is downtrending. It has underperformed by 38.75% the S&P500.

Analysts await Innophos Holdings, Inc. (NASDAQ:IPHS) to report earnings on August, 7. They expect $0.59 earnings per share, up 3.51 % or $0.02 from last year’s $0.57 per share. IPHS’s profit will be $11.53 million for 19.92 P/E if the $0.59 EPS becomes a reality. After $0.61 actual earnings per share reported by Innophos Holdings, Inc. for the previous quarter, Wall Street now forecasts -3.28 % negative EPS growth.

Ironwood Investment Management Llc holds 1.2% of its portfolio in Innophos Holdings, Inc. for 35,925 shares. Segall Bryant & Hamill Llc owns 984,342 shares or 1.01% of their US portfolio. Moreover, Frontfour Capital Group Llc has 0.85% invested in the company for 67,158 shares. The Maryland-based Investment Counselors Of Maryland Llc has invested 0.64% in the stock. Alpha Windward Llc, a Massachusetts-based fund reported 11,760 shares.

More important recent Innophos Holdings, Inc. (NASDAQ:IPHS) news were published by: which released: “Innophos Holdings (IPHS) Declares $0.48 Quarterly Dividend; 4.4% Yield” on April 20, 2018, also published article titled: “Innophos to Host First-Quarter 2018 Financial Results Conference Call on May 1”, published: “Innophos Holdings, Inc. Reports First-Quarter 2018 Results” on May 01, 2018. More interesting news about Innophos Holdings, Inc. (NASDAQ:IPHS) was released by: and their article: “Innophos Holdings’ (IPHS) CEO Kim Ann Mink on Q1 2018 Results – Earnings Call Transcript” with publication date: May 01, 2018.

Innophos Holdings, Inc. (NASDAQ:IPHS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: